BCV
BSX icon

Banque Cantonale Vaudoise’s Boston Scientific BSX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Buy
67,611
+1,288
+2% +$69.9K 0.4% 44
2026
Q1 		$4.16M Buy
66,323
+25,106
+61% +$2.01M 0.16% 125
2025
Q4 		$3.93M Sell
41,217
-3,392
-8% -$333K 0.14% 137
2025
Q3 		$4.36M Sell
44,609
-7,232
-14% -$749K 0.16% 113
2025
Q2 		$5.57M Buy
51,841
+19,827
+62% +$2.01M 0.23% 84
2025
Q1 		$3.23M Buy
+32,014
New +$3.22M 0.14% 141
2024
Q3 		$2.63M Buy
31,402
+4,169
+15% +$329K 0.11% 201
2024
Q2 		$2.1M Buy
27,233
+668
+3% +$48.9K 0.08% 226
2024
Q1 		$1.82M Buy
26,565
+886
+3% +$57K 0.07% 265
2023
Q4 		$1.48M Sell
25,679
-23,748
-48% -$1.27M 0.06% 280
2023
Q3 		$2.61M Buy
49,427
+8,625
+21% +$452K 0.13% 131
2023
Q2 		$2.21M Buy
40,802
+1,315
+3% +$68.7K 0.1% 172
2023
Q1 		$1.97M Sell
39,487
-187
-0.5% -$8.81K 0.1% 203
2022
Q4 		$1.83M Sell
39,674
-3,225
-8% -$140K 0.1% 200
2022
Q3 		$1.66M Sell
42,899
-213
-0.5% -$8.54K 0.09% 207
2022
Q2 		$1.61M Sell
43,112
-37
-0.1% -$1.51K 0.08% 232
2022
Q1 		$1.91M Sell
43,149
-2,894
-6% -$125K 0.08% 235
2021
Q4 		$1.96M Buy
46,043
+11,533
+33% +$485K 0.08% 243
2021
Q3 		$1.5M Sell
34,510
-3,990
-10% -$177K 0.06% 316
2021
Q2 		$1.65M Sell
38,500
-8,734
-18% -$367K 0.07% 279
2021
Q1 		$1.82M Sell
47,234
-2,254
-5% -$85.3K 0.09% 212
2020
Q4 		$1.78M Buy
49,488
+4,700
+10% +$169K 0.1% 188
2020
Q3 		$1.71M Buy
44,788
+3,387
+8% +$131K 0.11% 172
2020
Q2 		$1.45M Buy
41,401
+17,634
+74% +$635K 0.11% 190
2020
Q1 		$775K Buy
23,767
+1,676
+8% +$65.5K 0.07% 281
2019
Q4 		$998K Buy
+22,091
New +$924K 0.07% 293

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banque Cantonale Vaudoise's BSX Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Boston Scientific (BSX) stake by 1.9% in Q2 2026, buying an estimated $69.9K and bringing the position to 67,611 shares worth $2.89M. The position accounts for 0.4% of the portfolio, ranked #44.

Banque Cantonale Vaudoise first reported a position in BSX in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.57M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Banque Cantonale Vaudoise held 67,611 shares of Boston Scientific worth $2.89M as of Q2 2026.
  • Banque Cantonale Vaudoise bought 1,288 Boston Scientific shares in Q2 2026, an estimated $69.9K.
  • Boston Scientific made up 0.4% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #44 holding.
  • Banque Cantonale Vaudoise first reported a position in Boston Scientific in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's Boston Scientific position peaked at $5.57M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.